Fragment-based Differential Targeting of PPI Stabilizer Interfaces.
Guillory, X., Wolter, M., Leysen, S., Neves, J.F., Kuusk, A., Genet, S., Somsen, B., Morrow, J.K., Rivers, E., van Beek, L., Patel, J., Goodnow, R., Schoenherr, H., Fuller, N., Cao, Q., Doveston, R.G., Brunsveld, L., Arkin, M.R., Castaldi, P., Boyd, H., Landrieu, I., Chen, H., Ottmann, C.(2020) J Med Chem 63: 6694-6707
- PubMed: 32501690 
- DOI: 10.1021/acs.jmedchem.9b01942
- Primary Citation of Related Structures:  
6R5L, 6RHC, 6RJL, 6RJQ, 6RJZ, 6RK8, 6RKI, 6RKK, 6RKM, 6RL3, 6RL4, 6RL6, 6RM5, 6RM7, 6RP6, 6RWH, 6RWI, 6RWS, 6RWU, 6RX2, 6S39, 6S3C, 6S40, 6S9Q, 6SIN, 6SIO, 6SIP, 6SIQ, 6SLV, 6SLW, 6SLX - PubMed Abstract: 
Stabilization of protein-protein interactions (PPIs) holds great potential for therapeutic agents, as illustrated by the successful drugs rapamycin and lenalidomide. However, how such interface-binding molecules can be created in a rational, bottom-up manner is a largely unanswered question ...